InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Wigzell Hans Lennart Rudolf, Directeur. Director active across 1 company, notably Sarepta Therapeutics, Inc.. In total, 7 disclosures have been logged. Activity tracked since 7 March 2022. The latest transaction was filed on 12 December 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Wigzell Hans Lennart Rudolf is Director at Sarepta Therapeutics, Inc. (XNAS). He has 7 filings in total, and across the sampled recent filings from 2022-03-08 to 2025-03-11, the most common transaction nature is Attribution, with sum_buy_eur at 0 and sum_sell_eur at 0.